Agilent Technologies, Inc. $A Shares Sold by TCW Group Inc.

TCW Group Inc. lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 83.0% in the second quarter, Holdings Channel.com reports. The fund owned 4,795 shares of the medical research company’s stock after selling 23,479 shares during the quarter. TCW Group Inc.’s holdings in Agilent Technologies were worth $637,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Agilent Technologies in the 4th quarter worth about $549,158,000. AQR Capital Management LLC grew its holdings in shares of Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. grew its holdings in shares of Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares during the period. Balyasny Asset Management L.P. increased its position in Agilent Technologies by 192.0% during the 4th quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock worth $192,204,000 after purchasing an additional 928,821 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Agilent Technologies by 107.2% during the 1st quarter. SG Americas Securities LLC now owns 1,674,856 shares of the medical research company’s stock worth $190,900,000 after purchasing an additional 866,641 shares in the last quarter. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have weighed in on A shares. Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target on the stock. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 target price on the stock. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $148.55 on Friday. The business’s 50-day simple moving average is $135.38 and its 200 day simple moving average is $125.56. The company has a market cap of $41.96 billion, a P/E ratio of 29.83, a PEG ratio of 2.64 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the prior year, the business earned $1.31 EPS. Agilent Technologies’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.